Smoking Cessation Market Analysis, Growth Drivers and Future Scope

The global smoking cessation market is growing due to growing awareness about health problems associated with smoking and growing acceptance rate of smoking cessation products. On the basis of products, the electronic cigarette segment is expected to grow with the fastest rate during the forecasted period. Nicotine gums led the nicotine replacement therapy market; however, the nicotine lozenges are expected to grow with the fastest rate during the projected period. The innovation of products with better efficacy is also expected to pose as an opportunity for growth of the market. The massive unexplored market of smoking cessation industry in the developing economies is creating abundant growth opportunities for the global market.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/smoking-cessation-market/report-sample

Some of the major trends in the market are increasing number of collaborations and partnerships, growing number of merger and acquisitions, and growing number of product launches. Tobacco addition can lead to various serious health problems. Smoking cessation is the process of discontinuing tobacco smoking and it helps to reduce the risk of smoking related diseases. Nicotine withdrawal symptoms may include feeling hungrier than usual, having trouble thinking, craving for tobacco products, and feeling irritable, anxious and angry. According to the Centre for Disease Control and Prevention in 2010, approximately 7 out of every 10 adult cigarette smokers wanted to quit smoking completely.

Geographically, North America is expected to dominate the global market in the coming years, due to increasing number of smokers and growing awareness regarding health hazards associated with smoking. Asia-Pacific is expected to be the fastest growing region for the market, due to increasing awareness about the smoking cessation products and large pool of patients in the region. In addition, the Asia-Pacific market is growing due to increasing prevalence of health complications associated with smoking in the emerging countries, such as India and China.

Browse report at: https://www.psmarketresearch.com/market-analysis/smoking-cessation-market

Some of the companies operating in the global smoking cessation market are Johnson & Johnson, GlaxoSmithKline, Njoy Inc., Nicotek LLC, VMR Products LLC, British American Tobacco PLC, Reynolds American Inc., Perrigo, Pfizer, and Novartis.

Source: P&S Intelligence

Organ-on-Chip Market Overview, Share, Growth Drivers and Forecast by 2025

Global organ-on-chip market size is forecasted to reach $163.1 million by 2025. The growth in the market will be led by the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government grants and funds for research.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market/report-sample

The organ-on-chip market in APAC is expected to witness a significant growth during the forecast period. This growth is attributed to factors such as increasing healthcare expenditure, rising government initiatives and funding for healthcare R&D, and increase in the adoption of advanced technologies in the region.

There are many ongoing research to determine the potential of organ-on-chip as a new platform for biological analysis, funded by government organisations such as Chinese Academy of Sciences, and the National Key Scientific Instrument and Equipment Development Project, China. These factors will drive the growth of the APAC organ-on-Chip market in the future.

Browse report at: https://www.psmarketresearch.com/market-analysis/organ-on-chip-market

The players in organ-on-chip market are launching new and innovative products to enhance their product portfolio. For instance, in July 2017, Hmrel Corporation, launched HuRELviral application. The Hµrelviral microliver testing platform sustains hepatitis B virus (HBV) infection in actual human liver cells for over thirty days. This is expected to equip virologists with unprecedented insight into a drug candidate’s potential to cure chronic HBV.

Some of the other key players operating in the organ-on-chip industry include Emulate Inc., Mimetas B.V., TissUse GmbH, Kirkstall Ltd., CN Bio Innovations Ltd, Ascendance Biotechnology, Inc., Nortis, Inc., and Organovo Holdings, Inc.

Source: P&S Intelligence

Cell Isolation Market Insights, Share, Growth and Forecast by 2023

Global cell isolation market size is expected to reach $12.6 billion by 2023. The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market/report-sample

Based on product, the cell isolation market is categorized into consumables and instruments. Consumables generated revenue of more than $2.5 billion, accounting for 61.4% share, in the market in 2017, owing to the increased demand for consumables, such as reagents, kits, media, and sera, for cell isolation techniques.

The cell isolation market is also categorized into human cells and animal cells. During the forecast period, the market is expected to witness higher growth in human cell isolation, with a CAGR of 19.9%. Advancements in stem cell technologies for the treatment of various diseases are expected to drive the cell isolation market growth for this category.

Browse report at: https://www.psmarketresearch.com/market-analysis/cell-isolation-market


During the forecast period, the cell isolation market is projected to witness the fastest growth in APAC, with a CAGR of 22.1%. This is due to the increasing focus on basic and applied research by countries in the region. Besides, countries such as India and China have established research institutes promoting cell-based research. Hence, advanced healthcare infrastructure, rising adoption of innovative cell isolation products, and high demand for regenerative medicines are expected to drive the market growth in APAC in the coming years.

Some of the key players operating in the cell isolation industry are Terumo Corporation, General Electric Company, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Danaher Corporation, Merck KGaA, Miltenyi Biotec GmbH, and Becton, Dickinson and Company.

Source: P&S Intelligence

Anti-Aging Market Analysis, Share, Growth Drivers and Future Scope

Anti-aging market is forecasted to generate a revenue of $303.2 billion by 2025. The market is mainly driven by growing geriatric population, rise in technological advancements, growing medical tourism industry, and increasing volume of anti-aging cosmetic procedures.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/anti-aging-market/report-sample

In terms of the type of device, the anti-aging market is classified into radiofrequency devices, laser devices, anti-cellulite devices, and microdermabrasion devices. Radiofrequency (RF) devices are expected to be the largest segment in the global market in 2025. Many advantages of RF devices, which include skin tightening, aesthetic enhancement, cellulite, and body contouring are driving the growth of the market.

In terms of treatment, the anti-aging market is segmented into hair restoration, anti-pigmentation, anti-adult acne, liposuction, breast augmentation, chemical peel, and others. Hair restoration is expected to be the largest segment in the global market in 2025. One of the major factors driving the growth of the hair restoration market is significant increase in the number of hair transplantation procedures.

Browse report at: https://www.psmarketresearch.com/market-analysis/anti-aging-market

In terms of demography, the anti-aging market is classified into generation X, baby boomer, and generation Y. Generation X is expected to be the largest segment in the global market in 2025. Increase in the volume of aesthetic procedures on generation X is going to drive the growth of the market.

Major key players in the global anti-aging market are acquiring other aesthetic based manufacturers to expand their product portfolio for different type of skin conditions. For instance, in September 2018, Syneron Medical Ltd. acquired Ellipse A/S, a Danish medical device company that manufactures and markets laser based and intense pulse light (IPL) platforms for different types of medical and aesthetic skin treatments. This acquisition will help Syneron Medical Ltd. to strengthen its footprints in multi-application space and provide customers a comprehensive product portfolio.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-aging-market

Some of the other key players operating in the anti-aging market are The Procter and Gamble Company, Nu Skin Enterprises Inc., Lumenis Ltd., Home Skinovations Ltd., Allergan plc, The Estée Lauder Companies Inc., Coty Inc., L’Oréal S.A., Orlane S.A., Age Sciences Inc., and Alma Lasers GMBH.

Source: P&S Intelligence

Orthopedic Soft Tissue Repair Market Analysis, Share and Growth Drivers 2023

A soft tissue injury is the damage of ligaments, muscles and tendons of hip, knee, shoulder and elbow joint. A soft tissue injury usually occurs from a strain, sprain and continuous use of a particular part of the body and it can result in swelling, pain, bruising and loss of function. To cure soft tissue injury, the soft tissue repair procedure is used. On any soft tissue injury, Protection Rest Ice Compression Elevation (PRICE) principle should be immediately applied to minimize the soft tissue damage and to reduce inflammation caused by it. One of the methods to diagnose soft tissue damage is magnetic resonance imaging.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/orthopedic-soft-tissue-repair-market/report-sample

On the basis of surgeries, the global orthopedic soft tissue repair market can be broadly segmented as vaginal prolapse, achilles tendinosis repair, lateral epicondylitis, rotator cuff repair, anterior cruciate ligament and gluteal tendon. On the basis of applications, the global orthopedic soft tissue repair market can be broadly bifurcated as hernia repair, dental, dural repair, skin repair, vaginal sling procedures and breast reconstruction repair.

The rising trend towards safe and simple persistent surgeries and growth in number active lifestyle opting patients are driving the demand of the orthopedic soft tissue repair market. Moreover, with the increase in popularity of rough and energetic sports such as football, soccer and basketball, there had been a considerable increase in the number of soft tissue damages. Some of the factors driving the growth of orthopedic soft tissue repair market are rising geriatric population, increasing obesity rate, advanced medicinal technological advancements, and lack of substitutes.

Browse report at: https://www.psmarketresearch.com/market-analysis/orthopedic-soft-tissue-repair-market

North America had the largest share in global orthopedic soft tissue repair market in 2014, attributed to the increase in sports injury cases due to high share of sports activity in this region. Development of more advanced and useful soft tissue repair procedures in this region is one of the other important driving factors for soft tissue repair market in the region. Developed markets of west are heading towards maturity, and the growth is mainly anticipated from the developing countries of Asia-Pacific region. The growth in disposable income coupled with rising health consciousness among the middle class consumers is one of the major drivers for soft tissue repair market in Asia-Pacific region.

Some of the major competitors of the global orthopedic soft tissue repair market are Lifecell Corporation, Johnson & Johnson Services Inc., Smith & Nephew PLC, C.R Bard Inc., Wright Medical, Covidien PLC, Lifenet Health Inc., American Medical Systems Inc., Arthrex Inc., and Integra Lifesciences Corporation.

Source: P&S Intelligence